Lehrstuhl für Strahlentherapie


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC (2026) Girard N, Bar J, Baas P, Chouaid C, Christoph DC, Field JK, Fietkau R, et al. Journal article Approaches to needle navigation in interstitial brachytherapy using infrared tracking and radiography (2026) Kreß V, Merten R, Bert C, Strnad V, Fietkau R, Corradini S, Karius A Journal article Efficacy and safety of salvage brachytherapy for local recurrence after radiotherapy for prostate cancer (2026) Merten R, Strnad V, Lotter M, Kreppner S, Frei C, Schweizer C, Fietkau R, et al. Journal article Reply to: “Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology, ” “Key Methodological Considerations in the Interpretation of the CONKO-007 Trial, ” and “Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer” (2026) Fietkau R Journal article Brachytherapy in vulvar cancer: Clinical outcome and safety from a single center experience (2026) Oleszczuk A, Strnad V, Lotter M, Kreppner S, Strnad A, Frei C, Weissmann T, et al. Journal article Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis (2026) Oertel M, Dabaja B, Görlich D, Thomas BR, Sim V, Johnstone P, Hashmi A, et al. Journal article Radiotherapy and DNA damage response inhibitors modestly sensitize HNSCC to NK cell killing, with ATM inhibition more effective than ATR inhibition (2026) Steinsdörfer L, Zülch L, Schäfer A, Frey B, Corradini S, Fietkau R, Gaipl U, Jost T Journal article Comprehensive geometry-based plan quality score for lung VMAT (2026) Brand J, Szkitsak J, Lobão R, Axer BN, Pieper L, Ott O, Haderlein M, et al. Journal article Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy (2026) Filippi AR, Bar J, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, et al. Journal article Correction: Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversight (Frontiers in Oncology, (2025), 15, (1695468), 10.3389/fonc.2025.1695468) (2026) Dinç U, Sarkar J, Schubert P, Semrau S, Weissmann T, Karius A, Brand J, et al. Journal article, Erratum